Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis Viruses
- 15 January 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (2), 1069-1074
- https://doi.org/10.1128/jvi.77.2.1069-1074.2003
Abstract
Ebola virus causes lethal hemorrhagic fever in humans, but currently there are no effective vaccines or antiviral compounds for this infectious disease. Passive transfer of monoclonal antibodies (MAbs) protects mice from lethal Ebola virus infection (J. A. Wilson, M. Hevey, R. Bakken, S. Guest, M. Bray, A. L. Schmaljohn, and M. K. Hart, Science 287:1664-1666, 2000). However, the epitopes responsible for neutralization have been only partially characterized because some of the MAbs do not recognize the short synthetic peptides used for epitope mapping. To identify the amino acids recognized by neutralizing and protective antibodies, we generated a recombinant vesicular stomatitis virus (VSV) containing the Ebola virus glycoprotein-encoding gene instead of the VSV G protein-encoding gene and used it to select escape variants by growing it in the presence of a MAb (133/3.16 or 226/8.1) that neutralizes the infectivity of the virus. All three variants selected by MAb 133/3.16 contained a single amino acid substitution at amino acid position 549 in the GP2 subunit. By contrast, MAb 226/8.1 selected three different variants containing substitutions at positions 134, 194, and 199 in the GP1 subunit, suggesting that this antibody recognized a conformational epitope. Passive transfer of each of these MAbs completely protected mice from a lethal Ebola virus infection. These data indicate that neutralizing antibody cocktails for passive prophylaxis and therapy of Ebola hemorrhagic fever can reduce the possibility of the emergence of antigenic variants in infected individuals.Keywords
This publication has 19 references indexed in Scilit:
- Ebola Virus VP40-Induced Particle Formation and Association with the Lipid BilayerJournal of Virology, 2001
- Passive Transfer of Antibodies Protects Immunocompetent and Immunodeficient Mice against Lethal Ebola Virus Infection without Complete Inhibition of Viral ReplicationJournal of Virology, 2001
- Infectivity-Enhancing Antibodies to Ebola Virus GlycoproteinJournal of Virology, 2001
- Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing AntibodiesJournal of Virology, 2001
- Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent PatientsThe Journal of Infectious Diseases, 1999
- Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- The Nonstructural Small Glycoprotein sGP of Ebola Virus Is Secreted as an Antiparallel-Orientated HomodimerVirology, 1998
- Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horsesPublished by Springer Science and Business Media LLC ,1996
- GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases1Virology, 1995